Newsroom

Welcome to the IVX Health Newsroom. Here, you can find the latest news on our company, including future market expansions, leadership updates, new formulary offerings and more.

DAYTONA BEACH, Fla., April 7, 2022 /PRNewswire/ -- IVX Health, a national provider of infusion and injection therapy for adult and pediatric patients with multiple sclerosis, Crohn's disease, rheumatoid arthritis, and other complex chronic conditions, today announced the opening of two new centers in the greater Daytona Beach area.

Fort Myers, Fla., Feb. 17, 2022 /Business Wire/ -- IVX Health, a national provider of infusion and injection therapy for adult and pediatric patients with multiple sclerosis, Crohn’s disease, rheumatoid arthritis, and other complex chronic conditions, today announced the opening of three new centers in the Southwest Florida region this spring.

NASHVILLE, Tenn., Feb. 8, 2022 /Business Wire/ -- –IVX Health, a national provider of infusion and injection therapy for patients with complex chronic conditions, announced today the expansion of its injection formulary with the addition of Leqvio® (inclisiran), a new FDA-approved therapy by Novartis Pharmaceuticals Corporation indicated for the treatment of adult patients with clinical atherosclerotic cardiovascular disease (ASCVD) or heterozygous familial hypercholesterolemia (HeFH) who require additional LDL-C lowering.

NASHVILLE, Tenn., Dec. 15, 2021 /PRNewswire/ -- IVX Health, a national provider of infusion and injection therapy for patients with multiple sclerosis, Crohn's disease, rheumatoid arthritis, and other complex chronic conditions, today announced the completion of its rebrand of Precision Healthcare, following its acquisition in October 2020.

JACKSONVILLE, Fla., Oct. 19, 2021 /PRNewswire/ -- IVX Health, a national provider of infusion and injection therapy for patients with multiple sclerosis, Crohn's disease, rheumatoid arthritis, and other complex chronic conditions, today announced the opening of three new centers in the Jacksonville metropolitan area.

NASHVILLE, Tenn. and BOSTON, Mass., Sep. 21, 2021 /Business Wire/ -- IVX Health, a national provider of outpatient infusion centers, announced today the completion of a $100 million Series F minority investment from Great Hill Partners, a private equity firm that invests in high-growth, disruptive companies. Great Hill joins IVX Health’s existing investors including Linden Structured Capital, McKesson Ventures, Health Velocity Capital, and Nueterra Capital.

NASHVILLE, Tenn., Sep. [17], 2021 /PRNewswire/ — Modern Healthcare has named IVX Health as one of the Best Places to Work in Healthcare in 2021, an annual program that identifies and honors 150 outstanding companies and organizations in the healthcare industry nationwide. Modern Healthcare ranked IVX Health No. 48 overall in one of its two category designations. The award marks the third consecutive year IVX Health has been recognized in the prestigious Best Places to Work list.

INDIANAPOLIS, Feb. 16, 2021 - IVX Health, a national provider of infusion and injection therapy for patients with multiple sclerosis, Crohn’s disease, ulcerative colitis, and other complex chronic conditions, today announced the opening of three new centers in the Indianapolis metropolitan area.

IVX Health, a national provider of infusion and injection therapy for patients with multiple sclerosis, Crohn's disease, ulcerative colitis, and other complex chronic conditions, today announced the opening of two new centers in the Chicago metropolitan area. Conveniently located in the communities of Lombard and Naperville, IVX Health offers patients an alternative to hospital-based infusions – with the same high-quality standards and safety protocols. IVX Health reimagines the traditional experience for infusion patients with amenities such as guaranteed private suites that allow for proper social distancing – a meaningful benefit when considering the often hours-long infusion procedures. IVX Health is now accepting patients in both of its new Chicago locations, adding to its existing footprint of Chicago-based centers conveniently located in Glenview and Schaumburg.

October 14th, 2020–IVX Health, a national provider of infusion and injection therapy for patients with complex chronic conditions such as multiple sclerosis, Crohn’s disease, and rheumatoid arthritis, announced today its acquisition of Precision Healthcare, formerly a subsidiary of BAI Healthcare Services, Inc. Based in Nashville, Tenn., Precision operates 12 infusion centers across Tennessee and northern Arkansas. The acquisition financing was led by a preferred equity investment from Linden Capital Partners – a Chicago-based private equity firm focused exclusively on the healthcare sector – and joined by existing institutional investors McKesson Ventures, Health Velocity Capital, and Nueterra Capital.

Media Inquiries

Chase Pattison
Vice President, Marketing
[email protected]

Headquarters

IVX Health
214 Centerview Drive
Suite 250
Brentwood, TN 37027

Click here to find an IVX Health center near you.

Menu